Day: July 8, 2020

Hospitalis intègre un système d’acheminement sécurisé du code consolidé pour une meilleure traçabilité des médicamentsBoulogne-Billancourt, le 08 juillet 2020 – Hospitalis est un portail d’échanges sur lequel sont connectés 1650 établissements de santé privés et publics (soit 90% des établissements de santé) et près de 200 laboratoires pharmaceutiques. La plateforme permet de gérer les flux numériques BtoB logistiques entre établissements et industries des produits de santé. Avec Hospitalis, Cegedim e-business propose une offre intégrant : digitalisation, intéropérabilité, traçabilité et sécurisation. Ce dernier point est effectivement l’une des principales préoccupations de Cegedim e-business qui grâce au service de sérialisation d’Hospitalis, permet de tracer et de s’assurer de l’authenticité du médicament.Hospitalis, une réponse à...

Hässleholm, Sweden, July 8, 20203 Months March 2020 – May 2020Net sales 380.6 (520.3) MSEK.EBIT 38.1 (10.9) MSEK. Profit before tax 13.5 (10.0) MSEK. Net profit 17.6 (12.2) MSEK.Earnings per share, before and after dilution equals 0.71 (0.49) SEK.During the three month period 0 (0) wind turbines were taken into operations with a total installed capacity of 0 (0) MW.During the three month period the equivalent of 0 (1) wind turbines with an installed capacity of 0 (2.0) MW was handed over to customers.At the end of the period Eolus had 687 (421) MW under asset management.In March 2020 the project company Øyfjellet Wind AS, which Eolus has a construction management agreement with, signed a turbine supply agreement with Nordex regarding 72 wind turbines of the model N149 with a total installed capacity of 400 MW. A 20-year Premium Service...

Hässleholm den 8 juli 2020Verksamhetsårets tredje period 1 mars 2020 – 31 maj 2020Nettoomsättningen uppgick till 380,6 (520,3) MSEK.Rörelseresultatet uppgick till 38,1 (10,9) MSEK. Resultat före skatt uppgick till 13,5 (10,0) MSEK. Periodens resultat efter skatt uppgick till 17,6 (12,2) MSEK.Resultat per aktie före och efter utspädning uppgick till 0,71 (0,49) SEK.Under perioden togs 0 (0) nya vindkraftverk med en total effekt om 0 (0) MW i drift.Under perioden överlämnades motsvarande 0 (1) vindkraftverk med en total effekt om 0,0 (2,0) MW till kund.Vid periodens utgång omfattade koncernens förvaltningsverksamhet 687 (421) MW.Projektbolaget Øyfjellet Wind AS, som Eolus är byggnationsansvarig för, tecknade i mars 2020 turbinleveransavtal med Nordex omfattande 72 vindkraftverk av modell N149 med en total installerad effekt om 400 MW. Ett...

Karolinska Development makes a partial sale of its holdings in the portfolio company Aprea Therapeutics and receives a net of SEK 39 millionSTOCKHOLM, SWEDEN – July 8, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that it has sold shares in the portfolio company Aprea Therapeutics, Inc. KCIF Co-investment Fund KB – a holding company jointly owned by the European Investment Fund and Karolinska Development – has sold shares in Aprea in the same transaction. In total, the transaction comprises 1 percent of the total outstanding shares in Aprea and brings net approx. SEK 39 million to Karolinska Development. After the transaction, Karolinska Development has a remaining holding in Aprea through KDev Investment, which remains unchanged at approximately 9.5 percent of the total number of outstanding shares...

Karolinska Development säljer del av innehavet i portföljbolaget Aprea Therapeutics och erhåller netto 39 miljoner SEKSTOCKHOLM, SVERIGE 8 juli 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att man avyttrat aktier i portföljbolaget Aprea Therapeutics. KCIF Co-investment Fund KB – ett holdingbolag gemensamt ägt av Europeiska Investeringsfonden och Karolinska Development – har avyttrat aktier i Aprea i samma transaktion. Totalt omfattar transaktionen 1 procent av samtliga utestående aktier i Aprea och inbringar netto cirka 39 mkr till Karolinska Development. Efter transaktionen har Karolinska Development ett kvarvarande indirekt innehav i Aprea genom KDev Investment, vilket är oförändrat och uppgår till cirka 9,5 procent av det totala antalet utestående aktier.Aprea Therapeutics, Inc. är ett biofarmaceutiskt företag...

Good morning,Please find below the press release issued today.Best regards,Michele Moore DuhenGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | LondonTel.: +44 3709 053408Email: Michele.MooreDuhen@capgemini.com_____________________________79% of consumers are changing their purchase preferences based on social responsibility, inclusiveness, or environmental impactCapgemini research highlights a strong connection between sustainability and core-business benefits including increased customer loyalty and brand revenueParis, July 8, 2020 – A new report from the Capgemini Research Institute examines the impact sustainability has on consumer purchasing patterns and how well consumer product and retail (CPR) organizations understand consumer expectations. The report, “Consumer Products and Retail: How sustainability...

Bonjour,Vous trouverez ci-après le communiqué de presse diffusé ce jour.Bien cordialement,Florence LièvreGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | ParisTel.: +33 1 47 54 50 71Email : florence.lievre@capgemini.com_____________________L’engagement des marques en faveur du développement durable est un facteur déterminant de préférence d’achat pour 79% des consommateursSelon un rapport de Capgemini, l’engagement en faveur du développement durable influe positivement sur le cœur de métier des entreprises du secteur des biens de consommation et du commerce, notamment sur les questions de fidélité à la marque et sur les ventesParis, le 8 juillet 2020 – Un nouveau rapport du Capgemini Research Institute analyse les initiatives de développement durable des marques et leur impact sur les comportements d’achat et...

   Le projet d’offre et le Projet de Note en Réponse restent soumis à l’examen de l’AMF   COMMUNIQUE RELATIF AU DÉPÔT D’UN PROJET DE NOTE D’INFORMATION ÉTABLI PAR LA SOCIÉTÉ INGENICO GROUP   EN RÉPONSE

    This document is an unofficial English-translation of the press release relating to the filing of the draft response (projet de réponse) which was filed with the French Autorité des marches financiers on July 8, 2020 and which remains subject to its review: In the event of any differences between this unofficial English-language translation and the official French press release, the official French press release shall prevail. The Offer and the Draft Response Document remain subject to review by the AMF   PRESS RELEASE RELATING TO THE FILING OF THE DRAFT RESPONSE DOCUMENT PREPARED BY INGENICO GROUPIN RESPONSE TOTHE PROPOSED MIXED TENDER OFFER AS THE PRIMARY OFFER, ALONGSIDE A SECONDARY EXCHANGE OFFER AND A SECONDARY CASH OFFER FOR THE INGENICO SHARES UP TO AN OVERALL LIMIT OF 81% IN WORLDLINE SHARES AND 19% IN CASHANDTHE PROPOSED...

Worldline filed its proposed tender offer for Ingenico securities with the Autorité des marchés financiers (AMF)Ingenico’s board of directors issued a favorable reasoned opinion on the offerWorldline has filed the draft offer document, and Ingenico has filed a draft reply document, with the AMFThe proposed tender offer for Ingenico shares includes a primary mixed offer and, subject to a “mix and match” mechanism, a secondary exchange offer and a secondary cash offer:primary mixed offer: 11 Worldline shares and €160.50 for 7 Ingenico sharessecondary exchange offer: 56 Worldline shares in exchange for 29 Ingenico sharessecondary cash offer: €123.10 per Ingenico shareThe proposed tender offer for Ingenico OCEANEs includes an alternative between a mixed offer and a cash offer:mixed offer: 4 Worldline shares and €998 for...